Indiana University Infectious Diseases Research CRS

Site Details


Emerson Hall, Suite 421

545 Barnhill Drive

Indianapolis, IN. 46202


Get Directions

Site Type


CRS Coordinator

Patricia Anderson


CRS Leader

Samir Gupta


Site Trials

HIV (and comorbidities)

Closed to accrual

A5332: REPRIEVE Trial

In this study, people between the ages of 40 and 75 with HIV will be randomized (like flipping a coin) to take the pill pitavastatin OR a placebo (non-active pill) to see if pitavastatin can help prevent heart disease and death in people who are taking HIV medication. You will not know if you are taking pitavastatin or placebo. The REPRIEVE trial will enroll about 7500 people from several countries.